Latest Market Growth News

Page 2 of 20
Australian Ethical Investment Ltd posted record FY26 results with a 29% rise in net profit after tax and funds under management reaching $14.5 billion, driven by strong superannuation inflows and growth in private markets.
Claire Turing
Claire Turing
25 Aug 2026
Metal Powder Works secures its biggest-ever purchase order for pure copper powder from Embassy Powdered Metals, marking its debut in the copper infiltration segment and accelerating capacity expansion plans.
Maxwell Dee
Maxwell Dee
24 Aug 2026
Zip Co Limited (ASX: ZIP) reported a 46% rise in net profit to $116.4 million for FY26, driven by strong US and ANZ market growth and record cash earnings of $268.9 million. The company also announced an orderly wind down of its New Zealand operations to focus on its core markets.
Claire Turing
Claire Turing
20 Aug 2026
NZX has appointed seasoned investment executive Hishaam Mirza as its new Chief Executive, aiming to boost the exchange's scale, liquidity, and international relevance.
Claire Turing
Claire Turing
19 Aug 2026
oOh!media reported a 1.4% revenue increase to $340.9 million in 1H26 but saw adjusted underlying EBITDA fall 22.5% due to rising fixed rents and soft billboard demand. The company declared a 2 cent interim dividend and agreed to a $1.68 per share takeover scheme with I Squared Capital.
Elise Vega
Elise Vega
17 Aug 2026
Australian Clinical Labs (ASX: ACL) delivered a modest 1.7% underlying EBIT increase in FY26, navigating subdued revenue and rising labour costs with operational efficiencies and strategic initiatives.
Ada Torres
Ada Torres
17 Aug 2026
ReNerve Limited has gained marketing approval for its flagship NervAlign Nerve Cuff in India, marking a critical milestone in its global expansion and enabling commercial rollout in one of the world's largest nerve repair markets.
Ada Torres
Ada Torres
10 Aug 2026
Rua Bioscience has approved a $600,000 convertible note facility aimed at boosting inventory purchases to accelerate its UK market expansion following a major distribution deal.
Ada Torres
Ada Torres
10 Aug 2026
James Hardie Industries posted a 64% jump in Q1 FY27 net sales to $1.475 billion, powered by the AZEK acquisition and solid organic growth. The company exceeded EBITDA guidance and raised its full-year outlook, targeting robust sales and cash flow growth amid cautious housing market assumptions.
Victor Sage
Victor Sage
7 Aug 2026
Argent BioPharma's licensing partner Splash Beverage Group has launched the US veterinary development program for CannEpil®, targeting companion-animal oncology and chronic pain. Led by industry veteran Dr Hunter Land, the initiative follows a defined FDA regulatory pathway and could broaden CannEpil®’s commercial footprint beyond human neurology.
Victor Sage
Victor Sage
6 Aug 2026
ClearVue Technologies has secured Clean Energy Council approval for its ClearVue-Helios rooftop solar panels, enabling government subsidies and grid connection in Australia. This certification coincides with expanded commercial solar incentives, potentially lowering costs for customers.
Victor Sage
Victor Sage
6 Aug 2026
General Finance Limited has earned a credit rating upgrade to BB+ with a Stable Outlook from Equifax, reflecting robust loan book growth and strong financial discipline.
Claire Turing
Claire Turing
4 Aug 2026

Browse the archive

Full archive